Introduction
In a significant move to enhance research integrity, the U.S. Department of Health and Human Services (HHS) has finalized a new rule to ...
"What CITI Program is Reading" is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher educat...
Introduction
The U.S. Food and Drug Administration (FDA) has taken a significant stride towards modernizing clinical trials by releasing a draft guid...
"What CITI Program is Reading" is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher educatio...
Introduction
In today's world, virtual reality has become a powerful tool for enhancing educational experiences and providing interactive journeys. T...
"What CITI Program is Reading" is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher educat...
"What CITI Program is Reading" is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher educatio...
The Food and Drug Administration (FDA) recently released a draft guidance for industry titled “Use of Data Monitoring Committees in Clinical Trials....
The Office for Human Research Protections (OHRP) recently released the guidance, “General Instructions on the Informed Consent Posting Requirement (...
As of January 2, 2022, institutions will be required to submit OHRP incident reports, electronically, via the new online form (unless they are unable ...
